Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.
Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.

Market Analysis and Insights: Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market
The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, dPCR accounting for % of the Digital PCR (dPCR) and Real-Time PCR (qPCR) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Clinical segment is altered to an % CAGR throughout this forecast period.
China Digital PCR (dPCR) and Real-Time PCR (qPCR) market size is valued at US$ million in 2021, while the North America and Europe Digital PCR (dPCR) and Real-Time PCR (qPCR) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Digital PCR (dPCR) and Real-Time PCR (qPCR) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market.
Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Scope and Market Size
Digital PCR (dPCR) and Real-Time PCR (qPCR) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Digital PCR (dPCR) and Real-Time PCR (qPCR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
dPCR
qPCR
Segment by Application
Clinical
Research Institution
By Company
Thermo Fisher
Roche
QIAGEN
Bio-rad
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Cepheid
Sansure Biotech
Liferiver
Xian Tianlong
Shanghai Hongshi Medical Technology
Molarry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA